Tasauf Abedin Khanam Jemima

Two new Covid-19 medicines have been authorized by the World Health Organization, expanding to the arsenal of measures, which includes vaccines, for preventing severe sickness and death from the virus. The news comes as Omicron cases continue to flood hospitals around the world, with the WHO estimating that half of Europe will be sick by March. WHO experts claimed in a guideline published in the British medical journal the BMJ that treating severe or critical Covid patients with the arthritis medicine baricitinib in combination with corticosteroids resulted in increased survival rates and a reduction in the requirement for ventilators. Experts also recommended Sotrovimab, a synthetic antibody medication, for non-serious Covid patients who are at high risk of hospitalization, such as the elderly, persons with immunodeficiencies, or people with chronic conditions like diabetes. Since the outbreak in China in December 2019, the coronavirus has killed at least 5,540,918 individuals globally, according to an AFP report. In response to an increase of Omicron cases around the world, China has halted dozens of international flights, while Shanghai has curtailed tourist activity to prevent an increase in local Covid-19 infections. Meanwhile, British experts claim that, while young children are more likely to be admitted to hospitals than older children, the cases are minor and the overall picture is encouraging.